Persistence, reproducibility, and cost-effectiveness of an intervention to improve the quality of osteoporosis care after a fracture of the wrist: Results of a controlled trial

Osteoporosis International

Volumn 18, Issue 3, 2007, Pages 261-270

  Majumdar, S R ^a,b   Johnson, J A ^a,b   Lier, D A ^a,b   Russell, A S ^a   Hanley, D A ^c   Blitz, S ^a   Steiner, I P ^a   Maksymowych, W P ^a   Morrish, D W ^a   Holroyd, B R ^a   Rowe, B H ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b INSTITUTE OF HEALTH ECONOMICS   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cost effectiveness; Fragility fractures; Interventions; Outcomes; Quality improvement; Trials

Indexed keywords

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CANADA; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; FEMALE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PATIENT CARE; PATIENT COUNSELING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REPRODUCIBILITY; THERAPY DELAY; TREATMENT OUTCOME; WRIST FRACTURE;

AGED; AGED, 80 AND OVER; ALBERTA; BONE DENSITY CONSERVATION AGENTS; COST-BENEFIT ANALYSIS; EPIDEMIOLOGIC METHODS; FEMALE; FRACTURES, BONE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; QUALITY OF HEALTH CARE; QUALITY OF LIFE; TREATMENT OUTCOME; WRIST INJURIES;

EID: 33846920397     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-006-0248-1     Document Type: Article

References (30)

1. Physicians' guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, 2002 (http://www/nof.org/physguide.html; last accessed on August 1st, 2006)
2. Scientific Advisory Council, Osteoporosis Society of Canada (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Can Med Assoc J 167[Suppl]:S1-S34
3. Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS et al (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163:2052-2057
4. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T (2003) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures. Arch Intern Med 163:2165-2172
5. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366-373
6. Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS et al (2003) Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88:3482-3486
7. Hajcsar EE, Hawker G, Bogoch ER (2000) Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 163:819-822
8. Cuddihy MT, Gabriel SE, Crowson CS, Atkinson EJ, Tabini C et al (2002) Osteoporosis interventions following distal forearm fractures: a missed opportunity. Arch Intern Med 162:421-426
9. Eliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after fragility fracture: a systematic review. Osteoporos Int 15:767-778
10. Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR (2005) Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type-2 diabetes. Diabetes Care 28:783-788
11. Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M (2001) When is it cost-effective to change the behavior of health professionals? JAMA 286:2988-2992
12. Johnell O, Jönsson B, Jönsson L, Black D (2003) Cost effectiveness of alendronate for the treatment of osteoporosis and prevention of fractures. Pharmaco-economics 21:305-314
13. Tosteson AN, Jonsson B, Grima DT, O'Brien BJ, Black DM, Adachi JD (2001) Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions. Osteoporos Int 12:849-857
14. Schousboe JT, Nyman JA, Kane RL, Ensrud KE (2005) Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 142:734-741
15. Klotzbuecher CM, Ross PD, Landsman PB, Abbott III TA, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
16. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271-278
17. Cranney A, Guyatt GH, Griffith L, Wells G, Tugwell P, for the Osteoporosis Research Advisory Group (2002) Summary of meta-analyses of therapies for postmenopausal osteoporosis. IX. Endocrinol Rev 23:570-578
18. Tonino RP, Meunier PJ, Emkey RD, Rodriguez-Portales JA, Menkes CJ et al for the Phase III Osteoporosis Treatment Study Group (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109-3115
19. Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD et al for the Alendronate Phase III Osteoporosis Treatment Study Group (2004) Ten years' experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189-1199
20. Thomson MA, Oxman AD, Haynes RB (2005) Local opinion leaders to improve health professional practice and health care outcomes. The Cochrane Library. The Cochrane Database of Systematic Reviews, Issue 4
21. Alberta Health Care Insurance Plan (2004) Schedule of medical benefits (procedures and price list). Alberta Health and Wellness, Edmonton, Alberta, Canada
22. Alberta Health and Wellness (2004) Drug benefits list. Edmonton, Alberta, Canada
23. Alberta Health and Wellness (2003) Health Costing in Alberta - Annual Report. Edmonton, Alberta, Canada
24. Canadian Institute for Health Information (2003) Resource intensity weights and expected length of stay. Ottawa, Ontario, Canada
25. Statistics Canada (2002) Life tables-Canada, provinces and territories, 1995-1997 (84-537-XIE). Ottawa, Ontario, Canada
26. Jiang HX, Majumdar SR, Dick DA, Moreau M, Raso J et al (2005) Development and initial validation of a risk score for predicting in-hospital and one-year mortality in patients with hip fractures. J Bone Miner Res 20:494-500
27. Donaldson C, Currie G, Mitton C (2002) Cost effectiveness analysis in healthcare: contraindications. Br Med J 325:891-894
28. Higashi T, Shekelle PG, Adams JL, Kamberg CJ, Roth CP et al (2005) Quality of care is associated with survival in vulnerable older patients. Ann Intern Med 143:274-281
29. Cooper C, Atkinson EJ, Jacobsen SJ, O'Fallon WM, Melton LJ 3rd (1993) Population-based study of survival after osteoporotic fractures. Am J Epidemiol 137:1001-1005
30. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878-882